Arrhythmogenic right ventricular cardiomyopathy/Dysplasia (ARVC/D)

Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is a progressive genetic cardiomyopathy characterized by progressive fatty and fibrous replacement of ventricular myocardium. The clinical presentation is marked by ventricular arrhythmias, some fatal. The disease has evolved from a primary electrical/electrophysiological disorder (in the 1980s–1990s) to a diagnostic imaging conundrum (in the 2000s) to the current day understanding of a genetic cardiomyopathy caused by defects in cell–cell adhesion proteins or intracellular signaling components. The pathogenesis, clinical presentation, and the genetics of the disease are discussed in this review. © 2013 Wiley Periodicals, Inc.

[1]  H. Calkins,et al.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia clinical presentation and diagnostic evaluation: results from the North American Multidisciplinary Study. , 2009, Heart rhythm.

[2]  G. Thiene,et al.  Arrhythmogenic right ventricular cardiomyopathy: An update. , 2001, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[3]  M. Davies,et al.  Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. , 1997, Journal of the American College of Cardiology.

[4]  P. Syrris,et al.  Genetics of Right Ventricular Cardiomyopathy , 2005, Journal of cardiovascular electrophysiology.

[5]  D. Corrado,et al.  Arrhythmogenic right ventricular cardiomyopathy: an update , 2009, Heart.

[6]  J. Seidman,et al.  Chamber-specific cardiac expression of Tbx5 and heart defects in Holt-Oram syndrome. , 1999, Developmental biology.

[7]  Y. Oade,et al.  Arrhythmogenic right ventricular cardiomyopathy , 2011, BMJ Case Reports.

[8]  A. Crosby,et al.  Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease) , 2000, The Lancet.

[9]  G. Danieli,et al.  Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. , 2002, American journal of human genetics.

[10]  A. Keren,et al.  Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression , 2008, Nature Clinical Practice Cardiovascular Medicine.

[11]  S. Rizzo,et al.  Mouse Models in Arrhythmogenic Right Ventricular Cardiomyopathy , 2012, Front. Physio..

[12]  G. Thiene,et al.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia on the basis of the revised diagnostic criteria in affected families with desmosomal mutations , 2011, European heart journal.

[13]  R. Erbel,et al.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia: a review and update , 2011, Clinical Research in Cardiology.

[14]  J. Svendsen,et al.  Wide spectrum of desmosomal mutations in Danish patients with arrhythmogenic right ventricular cardiomyopathy , 2010, Journal of Medical Genetics.

[15]  Gian Antonio Danieli,et al.  Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. , 2005, Cardiovascular Research.

[16]  M. Weiss,et al.  Recurrent and founder mutations in the Netherlands: mutation p.K217del in troponin T2, causing dilated cardiomyopathy , 2010, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

[17]  S. Peters,et al.  The value of different electrocardiographic depolarization criteria in the diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2007, Journal of electrocardiology.

[18]  A. Angelini,et al.  In vivo evidence of apoptosis in arrhythmogenic right ventricular cardiomyopathy. , 1998, The American journal of pathology.

[19]  D. Corrado,et al.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia: clinical impact of molecular genetic studies. , 2006, Circulation.

[20]  Hugh Calkins,et al.  Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. , 2005, Journal of the American College of Cardiology.

[21]  S. Russell,et al.  Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia. , 2005, Heart rhythm.

[22]  R. Virmani,et al.  Arrhythmogenic right ventricular cardiomyopathy and fatty replacement of the right ventricular myocardium: are they different diseases? , 1998, Circulation.

[23]  E. Meinl,et al.  Myofibrillar myopathy with arrhythmogenic right ventricular cardiomyopathy 7: corroboration and narrowing of the critical region on 10q22.3 , 2008, European Journal of Human Genetics.

[24]  M. Midiri,et al.  Arrhythmogenic right ventricular dysplasia: MR features , 1997, European Radiology.

[25]  H. Calkins,et al.  Utility of SAECG in Arrhythmogenic Right Ventricle Dysplasia , 2003, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[26]  J. Towbin,et al.  The detection of cardiotropic viruses in the myocardium of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2002, Journal of the American College of Cardiology.

[27]  G. Breithardt,et al.  Age- and Training-Dependent Development of Arrhythmogenic Right Ventricular Cardiomyopathy in Heterozygous Plakoglobin-Deficient Mice , 2006, Circulation.

[28]  S. Russell,et al.  Electrocardiographic Features of Arrhythmogenic Right Ventricular Dysplasia , 2009, Circulation.

[29]  D. Corrado,et al.  Arrhythmogenic right ventricular cardiomyopathy , 2009, The Lancet.

[30]  G. Thiene,et al.  Desmin Mutations and Arrhythmogenic Right Ventricular Cardiomyopathy , 2013, The American journal of cardiology.

[31]  D. Corrado,et al.  Molecular biology and clinical management of arrhythmogenic right ventricular cardiomyopathy/dysplasia , 2010, Heart.

[32]  F. Rutten,et al.  2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). , 2014, European heart journal.

[33]  R. Hauer,et al.  Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy , 2012, European journal of heart failure.

[34]  N. Protonotarios,et al.  Cardiac abnormalities in familial palmoplantar keratosis. , 1986, British heart journal.

[35]  G. Thiene,et al.  Familial occurrence of right ventricular dysplasia: a study involving nine families. , 1988, Journal of the American College of Cardiology.

[36]  W. Mckenna,et al.  Gene for arrhythmogenic right ventricular cardiomyopathy with diffuse nonepidermolytic palmoplantar keratoderma and woolly hair (Naxos disease) maps to 17q21. , 1998, Circulation.

[37]  A. Nava,et al.  Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. , 1994, British heart journal.

[38]  Michael D. Schneider,et al.  Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. , 2006, The Journal of clinical investigation.

[39]  Stefan L. Zimmerman,et al.  Genotype-specific pattern of LV involvement in ARVD/C. , 2012, JACC. Cardiovascular imaging.

[40]  H. Calkins,et al.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia: An update , 2008, Current cardiology reports.

[41]  D. Pennell,et al.  Right ventricular arrhythmia: emergence of magnetic resonance imaging as an investigative tool. , 1997, European heart journal.

[42]  A. Biederman,et al.  Thromboembolic complications in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2006, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[43]  V. Barrios,et al.  Arrhythmogenic right ventricular dysplasia. , 2009, Journal of the American College of Cardiology.

[44]  G. Thiene,et al.  Structural and molecular pathology of the heart in Carvajal syndrome. , 2004, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[45]  M. Vorgerd,et al.  De novo desmin-mutation N116S is associated with arrhythmogenic right ventricular cardiomyopathy. , 2010, Human molecular genetics.

[46]  M. Link,et al.  Implantable Cardioverter-Defibrillator Therapy for Prevention of Sudden Death in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2003, Circulation.

[47]  Hugh Calkins,et al.  Desmosomal Dysfunction due to Mutations in Desmoplakin Causes Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy , 2006, Circulation research.

[48]  D. Stephan,et al.  Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). , 2001, Human molecular genetics.

[49]  G. Danieli,et al.  ARVD4, a new locus for arrhythmogenic right ventricular cardiomyopathy, maps to chromosome 2 long arm. , 1997, Genomics.

[50]  A. Skanes,et al.  Differentiating arrhythmogenic right ventricular cardiomyopathy from right ventricular outflow tract ventricular tachycardia using multilead QRS duration and axis. , 2006, Heart rhythm.

[51]  David Paul,et al.  Electrical synapses formed by connexin36 regulate inhibition- and experience-dependent plasticity , 2011, Proceedings of the National Academy of Sciences.

[52]  S. Russell,et al.  Arrhythmogenic Right Ventricular Dysplasia: A United States Experience , 2005, Circulation.

[53]  R. Hauer,et al.  Cardiac cell-cell junctions in health and disease: Electrical versus mechanical coupling. , 2009, Journal of molecular and cellular cardiology.

[54]  J. Hegesh,et al.  Pharyngeal mesoderm regulatory network controls cardiac and head muscle morphogenesis , 2012, Proceedings of the National Academy of Sciences.

[55]  Sean Connors,et al.  Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. , 2008, American journal of human genetics.

[56]  Hugh Calkins,et al.  A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. , 2008, The New England journal of medicine.

[57]  E. Behr,et al.  Homozygous Mutation of Desmocollin-2 in Arrhythmogenic Right Ventricular Cardiomyopathy with Mild Palmoplantar Keratoderma and Woolly Hair , 2008, Cardiology.

[58]  R. Hamilton,et al.  Right ventricular cardiomyopathy in the young: an emerging challenge. , 2009, Heart rhythm.

[59]  H. Calkins,et al.  Filtered QRS Duration on Signal‐Averaged Electrocardiography Predicts Inducibility of Ventricular Tachycardia in Arrhythmogenic Right Ventricle Dysplasia , 2003, Pacing and clinical electrophysiology : PACE.

[60]  R Frank,et al.  Right Ventricular Dysplasia: A Report of 24 Adult Cases , 1982, Circulation.

[61]  J. Saffitz,et al.  The Role of Endomyocardial Biopsy in ARVC: Looking Beyond Histology in Search of New Diagnostic Markers , 2011, Journal of cardiovascular electrophysiology.

[62]  G. Thiene,et al.  Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease). , 2004, Heart rhythm.

[63]  P. Elliott,et al.  Clinical Expression of Plakophilin-2 Mutations in Familial Arrhythmogenic Right Ventricular Cardiomyopathy , 2006, Circulation.

[64]  M. Hatzfeld.  The armadillo family of structural proteins. , 1999, International review of cytology.

[65]  G. Danieli,et al.  Ultrastructural evidence of intercalated disc remodelling in arrhythmogenic right ventricular cardiomyopathy: an electron microscopy investigation on endomyocardial biopsies. , 2006, European heart journal.

[66]  D. Corrado,et al.  Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases. , 1990, The American journal of medicine.

[67]  H. Calkins,et al.  Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs , 2012, Nature.

[68]  Yunqing Shi,et al.  Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. , 2003, Developmental cell.

[69]  L. Mestroni,et al.  A new locus for arrhythmogenic right ventricular dysplasia on the long arm of chromosome 14. , 1996, Genomics.

[70]  R. Schwartz,et al.  Genetic Fate Mapping Identifies Second Heart Field Progenitor Cells As a Source of Adipocytes in Arrhythmogenic Right Ventricular Cardiomyopathy , 2009, Circulation research.

[71]  G. Danieli,et al.  Mutations in Desmoglein-2 Gene Are Associated With Arrhythmogenic Right Ventricular Cardiomyopathy , 2006, Circulation.

[72]  S. Scherer,et al.  Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy. , 2010, Journal of the American College of Cardiology.

[73]  D. Corrado,et al.  CARDIOMYOPATHY Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis, and treatment , 2022 .

[74]  Petros Syrris,et al.  Clinical and Genetic Characterization of Families With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Provides Novel Insights Into Patterns of Disease Expression , 2007, Circulation.

[75]  L. Jordaens,et al.  Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: Pathogenic Desmosome Mutations in Index-Patients Predict Outcome of Family Screening Dutch Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Genotype-Phenotype Follow-Up Study , 2011, Circulation.

[76]  J. Towbin,et al.  Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy. , 2009, Journal of the American College of Cardiology.

[77]  D. Roberts,et al.  Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages , 2009, Nature.

[78]  F. Lescroart,et al.  Clonal analysis reveals common lineage relationships between head muscles and second heart field derivatives in the mouse embryo , 2010, Development.

[79]  P. Syrris,et al.  Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. , 2007, Journal of the American College of Cardiology.

[80]  Brian R. Anderson,et al.  Genetic Variation in Titin in Arrhythmogenic Right Ventricular Cardiomyopathy–Overlap Syndromes , 2011, Circulation.

[81]  Arrhythmogenic right ventricular cardiomyopathy with fibrofatty atrophy, myocardial oedema, and aneurysmal dilation , 2005, Heart.

[82]  H. Zimmer,et al.  Some aspects of cardiac heterogeneity , 1994, Basic Research in Cardiology.

[83]  R. B. Cole,et al.  Ebstein's malformation of the tricuspid valve in the neonate. Functional and anatomic pulmonary outflow tract obstruction. , 1967, The American journal of cardiology.

[84]  J. Saffitz,et al.  A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy. , 2007, American journal of human genetics.

[85]  Silvio Litovsky,et al.  Absent Pulmonary Valve with Tricuspid Atresia or Severe Tricuspid Stenosis: Report of Three Cases and Review of the Literature , 2000, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[86]  Ekow Oppon,et al.  Bmc Medical Genetics Arrhythmogenic Right Ventricular Cardiomyopathy Type 6 (arvc6): Support for the Locus Assignment, Narrowing of the Critical Region and Mutation Screening of Three Candidate Genes , 2005 .

[87]  Wojciech Zareba,et al.  Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, European heart journal.

[88]  G. Danieli,et al.  Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations. , 2005, European heart journal.

[89]  D. Corrado,et al.  Arrhythmogenic Right Ventricular Cardiomyopathy. , 2010, Cardiac electrophysiology clinics.

[90]  R. Longo,et al.  Magnetic resonance imaging in right ventricular dysplasia. , 1992, The American journal of cardiology.

[91]  H. Calkins,et al.  Electrocardiographic Features of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy According to Disease Severity: A Need to Broaden Diagnostic Criteria , 2004, Circulation.

[92]  M. Ashworth,et al.  Mutations in the Lamin A/C gene mimic arrhythmogenic right ventricular cardiomyopathy. , 2012, European heart journal.

[93]  J. Bourke,et al.  Clinical and electrophysiological differences between patients with arrhythmogenic right ventricular dysplasia and right ventricular outflow tract tachycardia. , 2003, European heart journal.

[94]  J. Saffitz.  Dependence of Electrical Coupling on Mechanical Coupling in Cardiac Myocytes: Insights Gained from Cardiomyopathies Caused by Defects in Cell‐Cell Connections , 2005, Annals of the New York Academy of Sciences.

[95]  Walter Birchmeier,et al.  Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy , 2004, Nature Genetics.